Search
 

Immunex to Build $500-Mil Rhode Island Plant

SEATTLE-The biopharmaceutical company plans to construct a manufacturing plant in West Greenwich, RI. The building is expected to help the company meet a growing demand for its products.

By Gina Binole | Updated on August 15, 2001

SEATTLE-Immunex Corp. plans to build a $500-million manufacturing plant–part of its BioNext Project–in Rhode Island. When completed, company officials say the facility will house the largest cell culture manufacturing center in the world.

“(This project) is a key element of the execution of our strategic plan designed to satisfy growing demand in existing and emerging markets,” says Peggy Phillips, executive vice president and chief operating officer at Immunex. “The construction of this new plant will make Immunex one of the world’s leaders in biotechnology manufacturing, a key goal given the success of our marketed products and our need for manufacturing pipeline products in the future.”

Want to continue reading?
Become a Free ALM Digital Reader.

Once you are an ALM digital member, you’ll receive:

  • Unlimited access to GlobeSt and other free ALM publications
  • Access to 15 years of GlobeSt archives
  • Your choice of GlobeSt digital newsletters and over 70 others from popular sister publications
  • 1 free article* every 30 days across the ALM subscription network
  • Exclusive discounts on ALM events and publications

*May exclude premium content
Already have an account?

NOT FOR REPRINT

© 2024 ALM Global, LLC, All Rights Reserved. Request academic re-use from www.copyright.com. All other uses, submit a request to [email protected]. For more information visit Asset & Logo Licensing.

GlobeSt

Join GlobeSt

Don't miss crucial news and insights you need to make informed commercial real estate decisions. Join GlobeSt.com now!

  • Free unlimited access to GlobeSt.com's trusted and independent team of experts who provide commercial real estate owners, investors, developers, brokers and finance professionals with comprehensive coverage, analysis and best practices necessary to innovate and build business.
  • Exclusive discounts on ALM and GlobeSt events.
  • Access to other award-winning ALM websites including ThinkAdvisor.com and Law.com.

Already have an account? Sign In Now
Join GlobeSt

Copyright © 2024 ALM Global, LLC. All Rights Reserved.